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Summary Introduction
Autosomal dominant cerebellar ataxia is a group of clin- Autosomal dominant cerebellar ataxia (ADCA) is a
ically and genetically heterogeneous disorders. We car- group of heterogeneous conditions (Harding 1982). The
ried out genomewide linkage analysis in 15 families with cardinal clinical feature is progressive ataxia and other
autosomal dominant pure cerebellar ataxia (ADPCA). cerebellar signs, although extracerebellar signs such as
Evidence for linkage to chromosome 19p markers was pyramidal or extrapyramidal signs, ophthalmoparesis,
found in nine families, and combined multipoint analy- amyotrophy, or peripheral neuropathy may be variably
sis reﬁned the candidate region to a 13.3-cM interval in present. Clinical or neuropathological classiﬁcations of
19p13.1-p13.2. The remaining six families were ex- ADCA sometimes have been unreliable, but identiﬁca-
cluded for this region. Analysis of CAG-repeat expan- tion of several distinct gene loci and causative genes
sion in the alpha1A-voltage-dependent calcium channel has made it possible to classify ADCA within molecular
(CACNL1A4) gene lying in 19p13.1, recently identiﬁed levels: spinocerebellar ataxia type 1 (SCA1) on chromo-
among 8 small American kindreds with ADPCA (spino- some 6p22-p23 (Yakura et al. 1974; Zoghbi et al. 1991;
cerebellar ataxia type 6 [SCA6]), revealed that 8 of the Kwiatkowski et al. 1993), SCA2 on 12q23-q24.1
15 families studied had similar, very small expansion in (Gispert et al. 1993), Machado-Joseph disease (MJD)/
this gene: all affected individuals had larger alleles (range SCA3 on 14q24.3-q32.1 (Takiyama et al. 1993; Steva-
of CAG repeats 21–25), compared with alleles observed nin et al. 1994), SCA4 on 16q22.1 (Gardner et al. 1994;
in neurologically normal Japanese (range 5–20 repeats). Flanigan et al. 1996), SCA5 on 11cen (Ranum et al.
Inverse correlation between the CAG-repeat number 1994), and SCA7 on 3p12-p13 (Benomar et al. 1995;
and the age at onset was found in affected individuals Gouw et al. 1995; David et al. 1996). The genetic hetero-
with expansion. The number of CAG repeats in ex- geneity likely accounts for some clinical and pathologi-
panded chromosomes was completely stable within each cal variations in ADCA. In addition, SCA1 (Orr et al.
family, which was consistent with the fact that anticipa- 1993), SCA2 (Imbert et al. 1996; Pulst et al. 1996; San-
tion was not statistically proved in the SCA6 families pei et al. 1996), and MJD/SCA3 (Kawaguchi et al. 1994)
that we studied. We conclude that more than half of have been demonstrated to be associated with unstable
Japanese cases of ADPCA map to 19p13.1-p13.2 and trinucleotide-CAG repeats, and the number of CAG re-
are strongly associated with the mild CAG expansion in peats is found to correlate with the variable age at onset,
the SCA6/CACNL1A4 gene. with the phenomenon of anticipation (i.e., younger age
at onset in successive generation), or with the progres-
sion in these diseases. Furthermore, CAG repeats in
these genes are in their coding region and are shown to
be translated into polyglutamine tracts that are sug-Received March 4, 1997; accepted for publication May 16, 1997.
gested to exert neurotoxic effect (Servadio et al. 1995;Address for correspondence and reprints: Dr. Hidehiro Mizusawa,
Department of Neurology, Faculty of Medicine, Tokyo Medical and Ikeda et al. 1996).
Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan. We as well as others have elsewhere reported that
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there is a distinct group of ADCA with only cerebellar 1997 by The American Society of Human Genetics. All rights reserved.
0002-9297/97/6102-0012$02.00 symptoms (autosomal dominant pure cerebellar ataxia
336
/ 9a2d$$jy49 08-01-97 13:06:34 ajhga UC-AJHG
337Ishikawa et al.: SCA6 Gene in Japanese ADPCA
[ADPCA]) (Harding 1982; Frontali et al. 1992; Ishi- tagmus (62.5%). Tendon reﬂexes were normal or
kawa et al. 1996). Neuropathologically, ADPCA shows slightly increased. Extracerebellar symptoms, such as
cerebellar cortical atrophy often with degeneration in pyramidal or extrapyramidal tract signs, ophthalmopar-
the inferior olivary nucleus (Hoffman et al. 1971; Eadie esis, or decreased sensation, were not seen. None of our
1991). Although ADPCA has been well recognized, the patients complained of migraine. Magnetic-resonance
SCA5 locus is so far the only gene locus identiﬁed for imaging demonstrated restricted atrophy in the cerebel-
this subtype (Ranum et al. 1994). However, our previ- lum in all individuals examined (n Å 35).
ous study on eight Japanese families with ADPCA ex- Reliable information on the age at onset was obtained
cluded the SCA5 locus, demonstrating that different ge- for 65 individuals, including 5 deceased subjects. The
netic mutations cause a similar phenotype (Ishikawa et age-at-onset range was 20–72 years, and the average
al. 1996). { SD age at onset was 49.5 { 10.7 years. Analysis of
To identify the gene(s) for ADPCA, we collected 15 difference in the age at onset in 28 parent-offspring pairs
families with ADPCA and initiated a genomewide search revealed that the phenomenon of anticipation was mild
for linkage. After screening all autosomes with 243 mi- but statistically signiﬁcant (age at onset was 2.8 { 7.7
crosatellite markers spaced in Ç15-cM intervals, we years earlier in offspring; P Å .042 by Wilcoxon’s test).
found evidence that in some of our families ADPCA was The most striking anticipation in our families was seen
linked to chromosome 19p13.1-p13.2. Very recently, in family P3 (age at onset 13.8 { 9.8 years earlier in
small expansions of trinucleotide (CAG) repeats in the offspring). In this family, two offspring (P3-8 and
alpha1A-voltage-dependent calcium channel (CAC- P3-13) noticed gait ataxia during their 20s, whereas the
NL1A4) gene (Ophoff et al. 1996) were identiﬁed in mother developed ataxia during her mid 40s. Anticipa-
eight small American kindreds and were designated tion was also suggested by the observation of an obligate
‘‘SCA6’’ (Zhuchenko et al. 1997). The chromosomal asymptomatic carrier (P1-15), who was not included in
location of the CACNL1A4 gene had been identiﬁed in the parent-offspring analysis. This individual was a 60-
the 19p13.1 region (Diriong et al. 1995). We analyzed year-old woman without apparent cerebellar signs. Her
this CAG repeat in the SCA6/CACNL1A4 gene and 31-year-old son (P1-22) already showed marked gait
found that Japanese families in which ADPCA was ataxia only 2 years after the onset.
linked to chromosome 19p also had mild CAG expan- After informed consent was obtained, blood samples
sion. Here we describe our linkage mapping to 19p13.1- were collected from 133 individuals, consisting of 68
p13.2, the mutational proﬁle of the SCA6/CACNL1A4 affected individuals, 57 at-risk family members, and 8
gene, and correlations between the CAG expansion and individuals married into these families. The genes for
clinical features in the ADPCA families that we studied. SCA1–SCA5 and SCA7 were excluded for these fami-
lies, either by the analysis of the CAG repeats in the
Subjects and Methods causative genes or by linkage analysis (data not shown).
ADPCA Families
Markers and GenotypingFifteen Japanese families were investigated (ﬁg. 1).
Two hundred forty-three polymorphic microsatelliteTen of these 15 families were the original residents of
markers were selected from either the Ge´ne´thon mapIbaraki Prefecture, and 2 other families (P13 and P14)
(Gyapay et al. 1994) or the Cooperative Human Linkagewere from nearby prefectures located in the center of
Center (CHLC) database (http: //www.chlc.org), toHonshu, the main island of Japan. The remaining three
cover whole autosomes with Ç15-cM intervals. Highfamilies were from distant areas: two families (P2 and
molecular-weight genomic DNA was extracted and wasP10) were from Kyushu and Shikoku, the islands in the
ampliﬁed by PCR using ﬂuorescein-labeled primers. Insouthwestern area of Japan, and one family (P8) was
brief, 125 ng of genomic DNA was ampliﬁed in afrom Aomori Prefecture, the northernmost prefecture of
25-ml volume with 2.5 pmol of each primer, 100 mMHonshu. All families were unrelated, and thus our co-
each dNTP, 10 mM Tris-HCL (pH 8.4), 50 mM KCl,hort could be considered to represent a certain propor-
1.5 mM MgCl2, 0.01% gelatin, and 0.5 units of Taqtion of ADPCA in Japan.
polymerase (Takara). Samples were processed at 94CClinical features of the 68 affected individuals were
for 3 min; for 30 cycles of 94C for 30 s, 55C for 30summarized as ‘‘pure’’ cerebellar ataxia and fulﬁlled the
s, and 72C for 3 min; and ﬁnally at 72C for 5 min.diagnostic criteria of ADPCA (Harding 1982; Frontali
Genotyping was performed by use of an Automatedet al. 1992; Ishikawa et al. 1996). Gait ataxia was invari-
Laser Fluorescence (A.L.F.TM) DNA Sequencer IIably the initial symptom and was the chief symptom
(Pharmacia Biotech) and was analyzed with Fragmentthroughout the clinical course. Other symptoms were
Manager (Pharmacia Biotech), as described elsewherecerebellar speech (93.8%), limb ataxia (92.2%), de-
creased muscle tonus (90.0%), and horizontal gaze nys- (Ishikawa et al. 1996).
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Figure 1 Fifteen families with ADPCA. Circles and squares denote females and males, respectively; and blackened symbols denote affected
individuals. Deceased individuals are denoted by diagonal lines through the symbols. Subjects who were sampled for genetic analysis are
indicated by numbers.
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Linkage Analysis D19S586–D19S394–D19S221– (D19S432)–D19S410–
D 19S434–D19S433–D19S178) were then analyzed. InPairwise and multipoint LOD scores (Z) were calcu-
the most informative family, P1, signiﬁcant Z values werelated by use of MLINK, ILINK, and LINKMAP in the
obtained for D19S394 (Zmax Å 4.92 at u Å .00) andcomputer software LINKAGE, version 5.1 (Lathrop et
D19S433 (Zmax Å 3.03 at u Å .00), and positive LODal. 1984; Terwilliger and Ott 1994). The disease was
scores (3 ú Zmax ú 2.5) also were obtained for D19S586,considered to be autosomal dominant with a gene fre-
D19S221, and D19S410. Three smaller families (P3, P5,quency of .00001. Recombination fractions (u) in men
and P10) also showed supporting data (Z ú 1.0) forand women were assumed to be equal. Since penetrance
D19S394, D19S221 andD19S432, whereas six others (P2,of the disease is a function of age, ﬁve age-dependent
P4, P6, P12, P14, and P15) showed signiﬁcantly negativepenetrance classes were established on the basis of the
Z values (i.e., õ02.0). Genetic heterogeneity was provedcumulative age-at-onset proﬁle of the pedigrees: class 1,
in D19S394 and D19S221, with signiﬁcant odds against0–29 years (3.4%); class 2, 30–39 years (16.9%); class
the ‘‘absence of linkage.’’ The conditional probabilities of3, 40–49 years (49.2%); class 4, 50–59 years (86.4%);
linkage suggested this linkage in nine families (P1, P3, P5,and class 5, ageú60 years (95%). For multipoint analy-
P7–P11, and P13). The combined pairwise LOD scoressis, the method of maximum Z (Zmax) minus 3 (Zmax
in these nine families reached Zmax values of 9.41 for0 3) was used to determine the support interval, and the
D19S394, 6.62 for D19S221, and 3.97 for D19S432, alldistance was calculated by use of the Haldane mapping
at u Å .00.function (Terwilliger and Ott 1994). The heterogeneity
Haplotype reconstruction placed the candidate regionanalysis within the families was performed by use of the
within a 16-cM region ﬂanked by D19S586 andprogram HOMOG, version 3.1 (Ott 1991).
D19S410: the centromeric boundary was placed at
Analysis of CAG Repeats in the SCA6/CACNL1A4 D19S410 by two recombinations in P5 and P10, and
Gene the telomeric boundary was placed at D19S586 by three
recombinations in P1, P7, and P10. However, haplo-CAG length polymorphism in the SCA6/CACNL1A4
types for the most tightly linked markers (D19S394–gene was determined by use of the S-5 primers described
D19S221–D19S432) were different in all families.elsewhere (Zhuchenko et al. 1997). PCR was performed
Multipoint analysis with six markers, D19S586–in a similar manner, with microsatellite markers, except
D19S394 –D19S221 –D19S432 –D19S410 –D19S434,that 250 mm of dimethyl sulfoxide (DMSO) was added
in these nine families demonstrated Zmax Å 10.94 forin each reaction, and the annealing temperature was
D19S221 (ﬁg. 2). The support interval was deﬁnedraised to 62C. Direct nucleotide-sequence analysis was
within a 13.3-cM interval in chromosome 19p13.1-also performed, to determine the accurate number of
p13.2; the region between 0.4 cM centromeric toCAG repeats and to determine the presence or absence
D19S586 and the location of D19S432. On the otherof any interrupting sequences within the CAG repeat.
hand, combined multipoint analysis of six families with-CAG-repeat polymorphism in the Japanese population
out linkage (P2, P4, P6, P12, P14, and P15) excludedwas determined by examination of 151 healthy volun-
linkage (Z õ 02.0) in a 40.3-cM interval spanning theteers who had neither neurological symptoms nor family
region between 20 cM telomeric to D19S586 and thehistory of ataxia. The relationship between the number
location of D19S434. (Detailed linkage data are avail-of CAG repeats and the age at onset was examined by
able from the authors.)a simple linear-regression analysis.
Analysis of CAG-Repeat Polymorphism in theClinical Comparison between Families with
SCA6/CACNL1A4 Gene in 19p13.1Expansions and Families without Expansions
The analysis of CAG-repeat length in neurologicallyClinical features of the SCA6 families were compared
normal Japanese individuals revealed that the lengthwith those of the non-SCA6 families. Statistical analysis
range was 5–20 repeats (ﬁg. 3). The distribution patternof anticipation was performed by Wilcoxon’s test, and
showed two major peaks; the largest peak was at 13statistical analysis comparing SCA6 and non-SCA6 fam-
repeats (allele frequency 42.1%), and the second peakilies was performed by the Mann-Whitney U-test or by
was at 11 repeats (allele frequency 23.2%). There werethe x2 test.
no sequences interrupting the CAG repeat in the normal
chromosomes. Two individuals harboring larger allelesResults
(18 and 20 CAG repeats) both 30 years of age, did not
Linkage Mapping to Chromosome 19p13.1-p13.2 have any neurological symptoms or family history of
ataxia.We screened all autosomes and found a possibility for
linkage to D19S432 in chromosome 19p (combined Zmax Analysis of all 15 ADPCA families showed that all
affected individuals in 8 19p-linked families (P1, P3, P5,of 1.65 at u Å .20). Eight nearby markers (D19S1034–
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lies (P5, P8, P9, and P10) had 22 repeats, two families
(P1 and P7) had 24 repeats, and 1 family (P3) had 25
repeats. The range in the number of CAG repeats in
normal chromosomes in SCA6 families was 7–19. Four
individuals with 19 repeats who were 70–75 years of
age were neurologically normal on examination.
One of the affected individuals (P13-4) was homozy-
gous for CAG expansions (both alleles 21 repeats). This
individual developed ataxic gait at the age of 58 years
and showed very mild ataxic symptoms at our examina-
tion of him 4 years after onset of his symptoms. His
clinical course was indistinguishable from that of his
mother (P13-1), who was heterozygous for CAG repeats
(18 and 21 repeats). Five asymptomatic individuals
(P1-15, P3-9, P8-4, P8-5, and P13-2) were also found
to carry the mild expansions. On the basis of haplotype
analysis, these individuals were predicted to carry the
disease genes.Figure 2 Combined multipoint LOD scores for nine families
(P1, P3, P5, P7–P11, and P13) with linkage to chromosome 19p. The The remaining seven families did not have expanded
combined Zmax of 10.94 was obtained at the location of D19S221, alleles (range 7–16 repeats). In all of these families link-
supporting linkage. The support interval, for the Zmax 0 3 method, age to 19p13.1-p13.2 had been excluded, except for a
revealed that the candidate locus lies in a 13.3-cM interval between
small family (P11) that showed inconclusive data for0.4 cM centromeric to D19S586 and the location of D19S432. Even
linkage (by multipoint analysis Zmax Å 0.23 forwhen family P11, later excluded for SCA6 expansion, was excluded
from this analysis, Zmax Å 10.71 was obtained at the same position. D19S221).
The precise locus of the SCA6/CACNL1A4 gene is also indicated.
Correlation between CAG-Repeat Length and Clinical
Features in the Eight Families with Expansions
P7–P10, and P13) had at least one allele with very mild The relationship between the length of the expanded
expansion. The range in the number of CAG repeats in CAG repeat of affected individuals (n Å 37) and their
the expanded (i.e., SCA6) chromosomes was 21–25 (ﬁg. ages at onset is shown in ﬁgure 4. A signiﬁcant correla-
3). The expanded alleles were completely stable within tion coefﬁcient (r) of 0.712 (r2 Å .507; P õ .001) was
each family: one family (P13) had 21 repeats, four fami-
Figure 3 Allele-frequency distributions in 302 normal chromo-
somes and in 44 SCA6 chromosomes, including those from 5 presymp- Figure 4 Scattergram of number of CAG repeats in SCA6 chro-
mosomes, versus age at onset in 37 affected individuals. An individualtomatic individuals and 1 homozygous individual. The range in the
number of CAG repeats in normal chromosomes was 5–20. The range (P13-4) homozygous for expansion (21 repeats) was excluded from
this calculation. A simple linear-regression analysis yielded a signiﬁ-in the number of repeats in expanded SCA6 chromosomes was 21–25.
Note that there was no repeat-number gap between the two groups. cant r of 0.712 (r2 Å .507; P õ .001).
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obtained for the age at onset and the repeat length in 4.9 years younger age at onset in offspring; P Å .046).
The difference in anticipation between the two groupsSCA6 chromosomes. No signiﬁcant correlation was ob-
served between the repeat length in the normal chromo- (SCA6 vs. non-SCA6) was not statistically signiﬁcant
(P Å .41). No other features were found that couldsomes in affected individuals and their ages at onset
(data not shown). differentiate the two groups.
Clinical Comparison between Families with
DiscussionExpansions and Families without Expansions
Clinical features of eight families with CAG expan- We performed a genomewide search for linkage and
found strong evidence for linkage to chromosome 19p13sion in the SCA6/CACNL1A4 gene (termed the ‘‘SCA6’’
families) were compared with those of seven families in the ADPCA families that we studied. This is the ﬁrst
successful linkage study in ADPCA other than SCA5without such expansion (termed the ‘‘non-SCA6’’ fami-
lies) (table 1). Between the two groups, there were no (Ranum et al. 1994). Haplotype and multipoint analyses
further reﬁned the candidate locus to a 13.3-cM regionstatistically signiﬁcant differences in either the age at
onset or the duration of illness at examination, and the around D19S221 in 19p13.1-p13.2. Exactly within the
candidate locus that we deﬁned, the mild CAG expan-clinical features in both groups were almost identical
and were summarized as ADPCA. However, the age at sion was identiﬁed in the CACNL1A4 gene and was
found to segregate with the disease in eight small Ameri-onset was signiﬁcantly younger in the SCA6 families
than in the non-SCA6 families (SCA6, 45.0 { 10.0 can kindreds with ADCA (i.e., SCA6 [Zhuchenko et al.
1997]). We examined this CAG repeat in the familiesyears; non-SCA6, 55.9{ 8.2 years; Põ .0001). Analysis
of anticipation did not prove signiﬁcant anticipation in studied and found similar, mild CAG expansions in eight
of them. These observations lead us to conclude that inSCA6 families (n Å 21 pairs; 2.1 years younger age at
onset in offspring; P Å .31), although great variability some of these Japanese families ADPCA maps to
19p13.1-p13.2 and is strongly associated with mildwas noted: the changes in offspring ranged from a
23-years-younger age at onset (i.e., anticipation) to an CAG expansion in the SCA6/CACNL1A4 gene.
The most signiﬁcant point that we conﬁrmed in this11-years-older age at onset. Anticipation in the non-
SCA6 families was statistically signiﬁcant (n Å 7 pairs; study is the pathogenic role of CAG-repeat expansions
Table 1
Comparison of Clinical Features in SCA6 Families and Non-SCA6 Families
SCA6 Families Non-SCA6 Families
(n Å 8)a (n Å 7)b
No. of patients examined 38 30
Age at examination (years) 61.2 { 14.3 66.6 { 10.8
Duration of illness (years) 16.5 { 11.9 13.2 { 9.3
Age at onset (years):c
Range 20–66 45–72
Averaged 45.0 { 10.0 (n Å 38) 55.9 { 8.2 (n Å 27)
Anticipation (years):e
Maternal transmission 02.8 { 9.8 (n Å 14)f 04.0 { 4.6 (n Å 6)g
Paternal transmission 0.7 { 5.5 (n Å 7)f 010 (n Å 1)
Overall 02.1 { 8.5 (n Å 21)f 04.9 { 4.8 (n Å 7)g
Clinical features (%):
Gait ataxia 100 100
Limb ataxia 91.9 92.6
Cerebellar speech 94.6 92.6
Nystagmus 62.2 63.0
Extracebellar signs 0 0
a Families P1, P3, P5, P7–P10, and P13.
b Families P2, P4, P6, P11, P12, P14, and P15.
c For 65 individuals, including 5 deceased subjects.
d Signiﬁcantly younger in SCA6 families compared with non-SCA6 families (P õ .0001).
e Calculated as age at onset in offspring minus age at onset in parent.
f Anticipation was not statistically signiﬁcant.
g Anticipation was proved to be statistically signiﬁcant (.01 õ P õ .05).
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in the SCA6/CACNL1A4 gene. The CAG-repeat expan- However, it should be noted that there was a substantial
variation in the age at onset in the same family with thesion in the SCA6/CACNL1A4 gene had three unique
and important aspects, compared with other CAG very same expansion: some showed striking ‘‘anticipa-
tion’’ whereas others exhibited the opposite. Accordingexpansions. First is that the size range of the expanded
CAG allele was small (21–27 repeats [Zhuchenko et to the statistical analysis (ﬁg. 4), Ç51% (r2 Å .507) of
the variation in age at onset can be accounted for byal. 1997] or 21–25 repeats [present study]) and was
completely within the normal range of CAG-repeat the CAG-repeat number, indicating that the remainder
of the variation remains to be explained. Although ascer-number in other diseases associated with CAG-repeat
expansions (La Spada et al. 1991; The Huntington’s tainment bias should always be considered in the deter-
mination of the age at onset, some other factors—in-Disease Collaborative Research Group 1993; Orr et al.
1993; Kawaguchi et al. 1994; Koide et al. 1994; Pulst cluding environmental factors—could be present that
inﬂuence the age at onset in individuals carrying theet al. 1996). Second is that a single nucleotide deletion
or the GrA nucleotide transition in the CACNL1A4 CAG expansion.
When clinical features of the American SCA6 kindredgene is identiﬁed as the cause of episodic ataxia (Ophoff
et al. 1996), suggesting that mutation other than tri- (Zhuchenko et al. 1997) are compared with those of the
Japanese SCA6 families that we studied, several identicalnucleotide repeat could be responsible for ADPCA.
Third is that the size of normal alleles was continuous features are found. Both groups of families show pre-
dominantly cerebellar ataxia with slow disease progres-up to 20 repeats and that no gap was observed between
the distribution of CAG-repeat numbers on the normal sion (Ishikawa et al. 1996). The ages at onset are also
similar in both groups; onset occurs mostly in the 40sand the SCA6 chromosomes. This is strikingly different
from the distributions in SCA1 (Orr et al. 1993), SCA2 and 50s in families with smaller expansions (21–24 re-
peats), whereas families with relatively larger expan-(Pulst et al. 1996), or MJD/SCA3 (Takiyama et al.
1995). No interrupting sequences were seen within the sions (25–27) show a tendency toward earlier onset (ﬁg.
4). Restricted cerebellar atrophy, as diagnosed on theCAG-repeat sequences in the SCA6/CACNL1A4 gene,
which was another difference from SCA1 (CAT inter- basis of magnetic-resonance imaging, is also a feature
common to both groups (Ishikawa et al. 1996). Theseruption [Chung et al. 1993; Jodice et al. 1994]) and
SCA2 (CAA interruption [Pulst et al. 1996]). At this features are quite similar and could be considered as
indicative of ADPCA (Harding 1982; Polo et al. 1991;moment, however, we cannot completely exclude the
possibility that individuals with larger alleles, such as Frontali et al. 1992). In addition to the cardinal cerebel-
lar symptoms, mild vibratory and proprioceptive sen-20 repeats, might develop ataxic symptoms in the future
or that such alleles are in the condition of premutation. sory loss, and choking were described in the American
SCA6 families. In our series of patients, however, sen-Although the mild CAG expansion in SCA6 appeared
to be pathogenic, the number of patients studied was sory dysfunction was not observed. Electrophysiological
studies, such as nerve conduction studies or somatosen-small, and the genotype-phenotype correlation was not
clear in the original study (Zhuchenko et al. 1997). In sory evoked potentials, were examined in ﬁve patients
with 22 or 24 repeats, but all patients were normal. Fewthe present study, we conﬁrmed that mild CAG expan-
sions similar to those found in the American SCA6 kin- subjects noticed dysphagia-like sensation. However,
these patients were ú70 years of age and had long (ú20dred are present in Japanese families with ADPCA. Fur-
thermore, an inverse correlation between the number of years) durations of illness. It will be important to exam-
ine whether these ‘‘extracerebellar’’ signs develop inCAG repeats and age at onset was demonstrated,
strongly suggesting that CAG expansion, even when SCA6, particularly in patients with larger expansions of
CAG repeats or with longer durations of illness.mild, plays a pathogenic role in SCA6.
Another important fact that we observed is that the Finally, our linkage data also showed that there are
still several families with ADPCA in Japan that do notCAG expansion in the SCA6/CACNL1A4 gene was
completely stable within the SCA6 families that we stud- link to chromosome 19p13.1-p13.2. SCA4 and SCA5
were both excluded for these families. The clinical fea-ied. This is strikingly different from the situation in other
diseases, in which CAG-repeat expansions are often un- tures of our non-SCA6 families are also those of pure
cerebellar ataxia, which is hardly distinguished fromstable and the transmission of unstable expansions is
thought to be an important, although not the only, mo- that in SCA6 families, except for the average age at onset
(table 1). Therefore, testing SCA6 mutation in patientslecular basis for anticipation (La Spada et al. 1992;
Chung et al. 1993; Duyao et al. 1993; Jodice et al. 1994; clinically diagnosed as ADPCA would be highly im-
portant. The present study has indicated the presence ofMaciel et al. 1995). In this context, highly ‘‘stable’’
transmission of the expanded CAG repeat appears to be anticipation in non-SCA6 families as well, suggesting
that similarly mild CAG expansion may also be presentconsistent with the fact that the anticipation was not
statistically proved in the SCA6 families that we studied. in this group. Further studies are needed to elucidate
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Gispert S, Twells R, Orozco G, Brice A, Weber J, Herederomolecular bases of this heterogeneous group of diseases
L, Scheuﬂer K, et al (1993) Chromosomal assignment ofclinically showing pure cerebellar ataxia.
the second locus for autosomal dominant cerebellar ataxia
(SCA2) to chromosome 12q23-24.1. Nat Genet 4:295–299
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